In a rush? You can use our Quick Contact Form to tell us the basic information about your case.
We are investigating Andexxa blood clot side effects cases for patients who developed a pulmonary embolism or deep vein thrombosis, causing them to be hospitalized or resulting in their death.
Here are some basic facts about these Andexxa drug injury cases seeking legal compensation:
- Andexxa (andexanet) is a treatment used when the reversal of anticoagulation is needed for life-threatening or uncontrolled bleeding in patients who are using Eliquis (apixaban) or Xarelto (rivaroxaban).
- For Andexxa drug injury cases to be successful, the patients must be using this anticoagulant reversal drug at the time of their pulmonary embolism (PE) or deep vein thrombosis (DVT) diagnosis.
- The FDA has been looking into an apparent increased rate of Andexxa blood clot side effects, which can lead to DVT and/or PE, as well as clotting-related deaths, compared with a different means to reverse anticoagulation.
- These cases would be filed as Andexxa drug injury lawsuits against AstraZeneca, the responsible pharmaceutical company.
We will continue to monitor this relatively new drug safety issue of Andexxa blood clot side effects, causing pulmonary embolism (PE) or deep vein thrombosis (DVT).
Free Case Evaluation for Andexxa Blood Clot Side Effects
We encourage you to submit a Case Evaluation Form online – it is free, confidential, and there is no obligation. Or, if you prefer, call 910-256-2971 to speak directly to attorney Tom Lamb about a possible Andexxa drug injury lawsuit. Either way, you will get Mr. Lamb’s impressions – not an intake person, a paralegal, or some other lawyer – based on his over 25 years of experience handling drug injury cases.
Most Recent Article About Andexxa Causing Blood Clots, PE, DVT
Andexxa Lawsuits: Pulmonary Embolism, Deep Vein Thrombosis, Blood Clot Cases Being Filed in 2026
Overview: Andexxa lawsuits involve pulmonary embolism (PE), deep vein thrombosis (DVT), and blood clots requiring hospitalization or resulting in death. These Andexxa lawsuits, being filed in 2026, would be brought against the responsible pharmaceutical company on behalf of people who suffered serious Andexxa side effects.
To read more of this article, click below:
Andexxa (andexanet) was recalled by AstraZeneca from the US market in December 2025.
Andexxa was given to patients using Eliquis (apixaban) or Xarelto (rivaroxaban) when they had an urgent need for the reversal of those anticoagulation drugs. Specifically, Andexxa was ordered by doctors in life-threatening or uncontrolled bleeding medical emergencies.
Following reports of patients given Andexxa developing a deep vein thrombosis (DVT), a pulmonary embolism (PE), or another serious blood-clot medical condition, the FDA started a drug safety investigation. The issue was whether there was an apparent increased rate of Andexxa-related blood clots, which can lead to DVT and/or PE, as well as clotting-related deaths, compared with other means to reverse anticoagulation.
Our law firm is investigating possible Andexxa lawsuits involving a pulmonary embolism (PE), deep vein thrombosis (DVT), or another serious blood-clot medical condition after a person was given Andexxa to reverse anticoagulation.
These Andexxa lawsuits would be filed against AstraZeneca, the pharmaceutical company responsible for Andexxa here in the US.
We point out that the doctors who ordered Andexxa would not be named as Defendants in these Andexxa lawsuits because the Andexxa drug label did not have any warnings about an increased risk of Andexxa-related blood clots, which can lead to DVT and/or PE, as well as clotting-related deaths.
As background, here are some earlier Drug Injury Law articles relevant to the Andexxa lawsuits:
- Andexxa Blood Clots and Clotting-Related Deaths: FDA November 2024
- Andexxa Blood Clot Cases Before Any AstraZeneca Drug Recall
- Andexxa Blood Clot Drug Injury Lawsuits
If you think you might have an Andexxa lawsuit against AstraZeneca, we encourage you to submit an Andexxa Blood Clots Case Evaluation Form online. Or call drug injury lawyer Tom Lamb at 910-256-2971 to discuss your Andexxa case.
Earlier articles about Andexxa blood clot side effects:
- Andexxa Blood Clot Drug Injury Lawsuits
- Andexxa Blood Clot Cases Before Any AstraZeneca Drug Recall
- Andexxa Blood Clots and Clotting-Related Deaths: FDA November 2024